Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Other Non-Current Liabilities (2019 - 2022)

Pulmonx has reported Other Non-Current Liabilities over the past 4 years, most recently at $179000.0 for Q2 2022.

  • Quarterly Other Non-Current Liabilities changed N/A to $179000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $179000.0 through Jun 2022, changed N/A year-over-year, with the annual reading at $179000.0 for FY2021, N/A changed from the prior year.
  • Other Non-Current Liabilities was $179000.0 for Q2 2022 at Pulmonx, roughly flat from $179000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $1.9 million in Q3 2020 and troughed at $179000.0 in Q4 2021.
  • The 4-year median for Other Non-Current Liabilities is $179000.0 (2021), against an average of $720400.0.